These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Preclinical systemic toxicity evaluation of chitosan-solid lipid nanoparticle-encapsulated aspirin and curcumin in combination with free sulforaphane in BALB/c mice. Thakkar A; Chenreddy S; Thio A; Khamas W; Wang J; Prabhu S Int J Nanomedicine; 2016; 11():3265-76. PubMed ID: 27499621 [TBL] [Abstract][Full Text] [Related]
44. Development and evaluation of co-formulated docetaxel and curcumin biodegradable nanoparticles for parenteral administration. Pawar H; Wankhade SR; Yadav DK; Suresh S Pharm Dev Technol; 2016 Sep; 21(6):725-36. PubMed ID: 26330159 [TBL] [Abstract][Full Text] [Related]
45. Galactosamine-modified PEG-PLA/TPGS micelles for the oral delivery of curcumin. Sun S; Du X; Fu M; Khan AR; Ji J; Liu W; Zhai G Int J Pharm; 2021 Feb; 595():120227. PubMed ID: 33484915 [TBL] [Abstract][Full Text] [Related]
46. Inducing sustained release and improving oral bioavailability of curcumin via chitosan derivatives-coated liposomes. Tian MP; Song RX; Wang T; Sun MJ; Liu Y; Chen XG Int J Biol Macromol; 2018 Dec; 120(Pt A):702-710. PubMed ID: 30170061 [TBL] [Abstract][Full Text] [Related]
47. Beta-carotene-Encapsulated Solid Lipid Nanoparticles (BC-SLNs) as Promising Vehicle for Cancer: an Investigative Assessment. Jain A; Sharma G; Thakur K; Raza K; Shivhare US; Ghoshal G; Katare OP AAPS PharmSciTech; 2019 Feb; 20(3):100. PubMed ID: 30721373 [TBL] [Abstract][Full Text] [Related]
48. Efficient Peroral Delivery of Insulin via Vitamin B12 Modified Trimethyl Chitosan Nanoparticles. Ke Z; Guo H; Zhu X; Jin Y; Huang Y J Pharm Pharm Sci; 2015; 18(2):155-70. PubMed ID: 26158281 [TBL] [Abstract][Full Text] [Related]
49. Chitosan nanoconstructs for improved oral delivery of low molecular weight heparin: In vitro and in vivo evaluation. Paliwal R; Paliwal SR; Agrawal GP; Vyas SP Int J Pharm; 2012 Jan; 422(1-2):179-84. PubMed ID: 22079712 [TBL] [Abstract][Full Text] [Related]
50. Mucoadhesive nanostructured lipid carriers (NLCs) as potential carriers for improving oral delivery of curcumin. Chanburee S; Tiyaboonchai W Drug Dev Ind Pharm; 2017 Mar; 43(3):432-440. PubMed ID: 27808665 [TBL] [Abstract][Full Text] [Related]
51. Multifunctional tumor-targeting nanocarriers based on hyaluronic acid-mediated and pH-sensitive properties for efficient delivery of docetaxel. Song S; Chen F; Qi H; Li F; Xin T; Xu J; Ye T; Sheng N; Yang X; Pan W Pharm Res; 2014 Apr; 31(4):1032-45. PubMed ID: 24154802 [TBL] [Abstract][Full Text] [Related]
52. [Research on thymopentin-loaded N-trimethyl chitosan nanoparticles administered through mouth]. Tang SW; Yuan XJ; Zhang ZR; Song QG; He Q Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Sep; 38(5):885-8. PubMed ID: 17953385 [TBL] [Abstract][Full Text] [Related]
53. Toward drug delivery into the brain: synthesis, characterization, and preliminary in vitro assessment of alkylglyceryl-functionalized chitosan nanoparticles. Molnár E; Barbu E; Lien CF; Górecki DC; Tsibouklis J Biomacromolecules; 2010 Nov; 11(11):2880-9. PubMed ID: 20919693 [TBL] [Abstract][Full Text] [Related]
54. Biological voyage of solid lipid nanoparticles: a proficient carrier in nanomedicine. Ali H; Singh SK Ther Deliv; 2016 Oct; 7(10):691-709. PubMed ID: 27790956 [TBL] [Abstract][Full Text] [Related]
55. Chitosan-starch nanocomposite particles as a drug carrier for the delivery of bis-desmethoxy curcumin analog. Subramanian SB; Francis AP; Devasena T Carbohydr Polym; 2014 Dec; 114():170-178. PubMed ID: 25263878 [TBL] [Abstract][Full Text] [Related]
56. Topical delivery of tetrahydrocurcumin lipid nanoparticles effectively inhibits skin inflammation: in vitro and in vivo study. Kakkar V; Kaur IP; Kaur AP; Saini K; Singh KK Drug Dev Ind Pharm; 2018 Oct; 44(10):1701-1712. PubMed ID: 29938544 [TBL] [Abstract][Full Text] [Related]
57. Oral immunization of mice with Omp31-loaded Abkar M; Fasihi-Ramandi M; Kooshki H; Sahebghadam Lotfi A Int J Nanomedicine; 2017; 12():8769-8778. PubMed ID: 29263667 [TBL] [Abstract][Full Text] [Related]
58. Preparation and Characterization of an Oral Norethindrone Sustained Release/Controlled Release Nanoparticles Formulation Based on Chitosan. Altaani BM; Al-Nimry SS; Haddad RH; Abu-Dahab R AAPS PharmSciTech; 2019 Jan; 20(2):54. PubMed ID: 30617756 [TBL] [Abstract][Full Text] [Related]
59. Antidepressant effects of curcumin and HU-211 coencapsulated solid lipid nanoparticles against corticosterone-induced cellular and animal models of major depression. He X; Zhu Y; Wang M; Jing G; Zhu R; Wang S Int J Nanomedicine; 2016; 11():4975-4990. PubMed ID: 27757031 [TBL] [Abstract][Full Text] [Related]
60. A hybrid design to optimize preparation of lopinavir loaded solid lipid nanoparticles and comparative pharmacokinetic evaluation with marketed lopinavir/ritonavir coformulation. Ravi PR; Vats R; Dalal V; Murthy AN J Pharm Pharmacol; 2014 Jul; 66(7):912-26. PubMed ID: 24697749 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]